“Grow your own bone” might not sound like much of a business slogan, since even children do just that naturally. But EpiBone, a two-year-old company based in Harlem, New York, has adopted the slogan ...
This is a world, the WIRED innovation fellow pointed out, that we are already living in. "Every cell in your body has a voltage across it, and mitochondria convert energy 10,000 times more efficiently ...
Process uses stem cells, 3-D printer to produce customized bone grafts Doctors perform almost a million bone-graft surgeries each year in the United States, and despite many advancements in medicine, ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As the CEO and co-founder of EpiBone, Nina Tandon is using stem cells ...
If you've ever broken a bone, you know the process to recovery is slow and painful. Now imagine neither splint nor surgery were enough to seal the fracture. Instead, your doctor says you need a bone ...
Small, woman-founded biotechnology company EpiBone, Inc. will create 90 jobs in Jersey City, NJ with the help of NJEDA Emerge tax credits. EpiBone, Inc. will receive up to $3.5 million over seven ...
JERSEY CITY, N.J., July 24, 2023 /PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The treatment, ...
- Potential breakthrough technology for stem-cell based bone replacement NEW YORK, May 22, 2019 /PRNewswire/ -- EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has ...
During its meeting March 8, the New Jersey Economic Development Authority (NJEDA) voted to approve EpiBone Inc. to receive up to $3.5 million over seven years in Emerge tax credits, setting the stage ...
NEW YORK, Nov. 8, 2024 /PRNewswire/ -- EpiBone, Inc., a leading regenerative medicine company at the forefront of skeletal repair, announces the successful close of a convertible note funding round ...
NEW YORK, May 22, 2019 /PRNewswire/ -- EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results